Past Pharmacy Residents
|
Year |
Resident |
Project(s) |
Post-residency Activity |
Certification |
|
2023-2024 |
Chrystal Cardoza |
Evaluation of Vancomycin Dosing in Pediatric Patients at a Community Hospital: A Descriptive Analysis |
PGY-2 Infectious Diseases Baystate Health Medical Center Springfield, Massachusetts |
|
|
2023-2024 |
John Luke Garber |
Financial Impact of Clinical-Pharmacist-Led Medication Therapy Management Clinic in the Context of 340B Drug Pricing at a Regional Health System |
PRN Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
|
|
2023-2024 |
Kaci White |
Evaluation of Antibiotic Appropriateness for the Treatment of Urinary Tract Infections for Patients Discharged from Multi-Campus Community Health System Emergency Departments |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
|
|
2022-2023 |
Sarah El-Koubysi |
Diagnostic Patterns of Cefepime-Related Neurotoxicity in Critically-Ill Patients |
IBD Pharmacist Specialist SSM Health Oklahoma City, Oklahoma |
|
|
2022-2023 |
Trevor Sanders |
Clinical Outcomes Associated with Beta-Lactam Antibiotic Treatment in Critically Ill Patients with Augmented Renal Clearance |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
|
|
2022-2023 |
Carley Welch |
Minimizing Altered Mental Status: An In-Depth Analysis of Diphenhydramine Dosing in Elderly Patients |
Staff Pharmacist Ascension St. John Medical Center Tulsa, Oklahoma |
|
|
2021-2022 |
Miranda Brewer |
Optimizing Treatment of Beta-Blocker and Calcium Channel Blocker Overdose in the Emergency Department: A Case Series and Review of the Literature |
ICU Clinical Pharmacist Texoma Medical Center Denison, Texas PGY-2 Critical Care 2022-2023 Methodist Dallas Medical Center Dallas, Texas |
BCCCP |
|
2021-2022 |
Leith Prise |
The Effects of Liposomal Bupivacaine on Patient Length of Stay and Opioid Use Status Post Colorectal Surgery |
Comprehensive Medication Management Pharmacy Specialist INTEGRIS Health Oklahoma City, Oklahoma |
BCPS |
|
2021-2022 |
Brock Snelson |
Revenue Analysis Comparing Reimbursement Rates of Cetuximab and Panitumumab in Patients with EGFR-Positive Metastatic Colorectal Cancer for a Hospital-Based Outpatient Infusion Center |
Clinical Pharmacist Baylor Scott & White Temple, Texas |
BCPS |
|
2020-2021 |
Michaela Metts |
Detailing the Gaps: An In-depth Analysis of Adverse Drug Reaction Surveillance and Reporting in a Community Hospital |
Pharmacy Consultant Oklahoma State Department of Health Oklahoma City, Oklahoma Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
MBA, BCPS, AAHIVP |
|
2020-2021 |
Cong Vu |
Impact of a Pharmacist-Driven Penicillin Skin Testing Protocol in a Community Hospital |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2020-2021 |
Charles Whitman |
Comparing the Safety and Efficacy of AUC-Based vs. Traditional, Trough Monitoring of Vancomycin in Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia |
Clinical Pharmacy Practitioner, Infectious Diseases Central Arkansas Veterans Healthcare System Little Rock, Arkansas PGY-2 Infectious Diseases 2021-2022 U.S. Department of Veterans Affairs Oklahoma City, Oklahoma |
|
|
2019-2020 |
Jerricah Franz |
Pharmacist-driven, fixed-dose, four-factor prothrombin complex concentrate (4F-PCC) protocol for major bleeds |
Clinical Pharmacist North Central Baptist Hospital San Antonio, Texas |
|
|
2019-2020 |
Julia Kaminski |
Impact of A Pharmacist Driven Opioid Stewardship Program in An Inpatient Setting |
Prescription Drug Monitoring Program Coordinator Clinical Pharmacy Specialist Coatesville VA Medical Center Coatesville, Pennsylvania |
|
|
2019-2020 |
Emily Deremiah |
Impact of a Procalcitonin-Guided Algorithm on Antibiotic Duration in Patients Admitted for Sepsis and Community-Acquired Pneumonia |
Critical Care Pharmacist University Health System San Antonio, Texas PGY-2 Critical Care 2020-2021 University Health System San Antonio, Texas |
BCCCP |
|
2018-2019 |
Danielle Norris (Trierweiller) |
Impact of a Pharmacist-driven, AUC-based Therapeutic Drug Monitoring Approach on Outcomes in Patients at High Risk for Vancomycin –related Nephrotoxicity |
Clinical Coordinator SSM Health Oklahoma City, Oklahoma |
BCPS |
|
2018-2019 |
K. Alex Ehrhart |
Pharmacy Impact on Narcotic Overrides in a Community Hospital Emergency Department |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2018-2019 |
Kathleen Sullivan |
Pharmacist Role in Optimization of Programmed Death Ligand (PD-L1) Product Selection Based on Reimbursement Data |
Hematology/Oncology Safety Evaluator at the FDA Silver Spring, Maryland PGY 2 Oncology 2019-2020 NorthShore University HealthSystem Evanston, Illinois |
BCOP |
|
2017-2018 |
Jaclyn Coffey |
Impact of Skin Testing for Penicillin Allergy in Self-Reported Penicillin Allergic Patients on the Use of Fluoroquinolones, Carbapenems, Aztreonam and Vancomycin in a Community Hospital |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2017-2018 |
Mona Kamali |
Impact of a Pharmacist-Driven Probiotic Protocol on the Incidence of Antibiotic- and Clostridium difficile-Associated Diarrhea in Hospitalized Patients Receiving Antibiotic Therapy |
Clinical Pharmacist Texas Health Denton, Texas |
|
|
2017-2018 |
Michael Wisner, Jr. |
Evaluating the impact of pharmacy driven interventions on patients with hyperglycemia who have been identified by use of a clinical surveillance software system |
Informatics Pharmacist Johns Hopkins Health System Baltimore, Maryland PGY-2 Informatics 2018-2019 Vanderbilt University Nashville, Tennessee |
|
|
2016-2017 |
Victoria Felder |
The Standardization of Admission and Specialty Order Sets to Minimize Duplicate Medication Orders |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2016-2017 |
Lauren May |
Evaluation of Urinary Tract Infection (UTI) Management in a Community Hospital with Subsequent Pathway Development and Implementation |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2016-2017 |
Robert Holliday |
Evaluation of the Conversion from Medication Charge on Dispending to Charge on Administration in a Community Hospital |
Clinical Pharmacy Specialist Saint John Health System Tulsa, Oklahoma |
BCPS |
|
2015-2016 |
Chris Brown |
Shifting from Premixed Nicardipine Injection to Nicardipine Prepared by the Pharmacy: Is It Worth It? |
Clinical Pharmacy Specialist and Residency Program Director Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2015-2016 |
Jacqueline Medina |
Development and Implementation of a Heparin-Induced-Thrombocytopenia Protocol and Implications on Patient Management and Cost |
Staff Pharmacist The Hospitals of Providence El Paso, Texas |
BCPS, BCPPS |
|
2015-2016 |
Whitney Rohlman |
Evaluation of Pyxis Overrides and Development of Policies to Promote Improvement |
Director of Pharmacy Pratt Regional Medical Center Pratt, Kansas |
BCPS |
|
2014-2015 |
Elizabeth Rathgeber |
Appropriateness of Iohexol and Iodixanol Use for Prevention of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization |
Clinical Pharmacist The Children’s Hospital at OU Medical Center Oklahoma City, Oklahoma |
|
|
2014-2015 |
Samantha Sepulveda |
Development and Implementation of a Protocol for Reversing the Effects of Anticoagulants for Use in a Community Hospital |
Pharmacist Oklahoma Heart Hospital South Oklahoma City, Oklahoma |
|
|
2014-2015 |
Lysse Vadder |
Analysis and Reduction of Adverse Drug Events Associated with Opioid Use in the Community Hospital Setting |
Clinical Pharmacist Integris Bass Baptist Health Center Enid, Oklahoma |
BCPS, SIDP |
|
2013-2014 |
Justin Booth |
Impact of Nutrition Support Team Implementation on Parenteral Nutrition Practices in a Community Hospital |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCEMP |
|
2013-2014 |
Kimberly Whitley (Curley) |
Development and Implementation of a Standardized Risk Stratification Protocol for Safe Handling of Hazardous Drugs According to NIOSH |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2013-2014 |
Minh Truong |
War on Pharmaceutical Waste |
Institutional Pharmacist Mayo Clinic Jacksonville, Florida |
|
|
2012-2013 |
Shamama Burney |
Appropriateness of Acid Suppression Therapy in a Community Hospital |
PACT Clinical Pharmacy Specialist Phoenix Veterans Health Care System, Northeast Clinic Scottsdale, Arizona |
|
|
2012-2013 |
Sarah Payne |
Evaluation and Implementation of a Multi-dose Medication Dispensing at Discharge Policy and Procedure |
Chief Operating Officer Health Candi, Inc. PGY2 Residency – Ambulatory Care 2013-2014 University of Oklahoma College of Pharmacy Oklahoma City, Oklahoma |
|
|
2012-2013 |
Tiffany Sanders (White) |
Conversion from Activated Partial Thromboplastin Time (aPTT) to Antifactor Xa Levels for Monitoring of Unfractionated Heparin (UFH) Infusions |
PRN Pharmacist St. Anthony Hospital Shawnee, Oklahoma |
|
|
2011-2012 |
Austin Bertram |
Development and Evaluation of a Program to Document Pharmacist Order Processing Interventions |
Pharmacy Infusion Manager Coram CVS/Specialty Infusion Oklahoma City, Oklahoma |
|
|
2011-2012 |
Jenny Stemm |
Conversion to Medication Charge upon Administration in a Community Hospital |
Manager of Pharmacy Services Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2011-2012 |
Karen Thompson |
Implementation of Risk Evaluation and Mitigation Strategy (REMS) Requirements and Compliance in the Hospital Setting |
Manager of Pharmacy Services and Medication Safety Mercy Health System Oklahoma City, Oklahoma |
BCPS |
|
2010-2011 |
Trevor Knol |
Evaluation of Inappropriate Medication Use in Hospitalized Patients Based on the Beers Criteria |
Clinical/Staff Pharmacist Oklahoma Heart Hospital Oklahoma City, Oklahoma |
|
|
2010-2011 |
Stefanie Stogsdill |
Implementation of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency |
Clinical Coordinator of Pharmacy Services Northeastern Health System Tahlequah, Oklahoma |
BCPS |
|
2009-2010 |
No Residents |
|||
|
2008-2009 |
Jerri Cody |
Increasing Pharmacist Review of Medications Prior to Retrieval from Automated Dispensing Cabinets |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
|
|
2008-2009 |
Lisa Mayer |
Development of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency |
Clinical Pharmacist Oklahoma Heart Hospital South Oklahoma City, Oklahoma |
BCPS |
|
2007-2008 |
No Residents |
|||
|
2006-2007 |
Lyndsay Sheperd |
Trends in Treatment of Clostridium difficile associated Disease in a Community Hospital Setting |
Critical Care Pharmacy Specialist Texas Health Presbyterian Hospital Forney, Texas PGY2 Critical Care 2007-2008 Memorial Hermann Hospital Houston, Texas |
BCPS BCCCP |
|
2005-2006 |
Emily Lam (Babcock) |
Improved Carbapenem Utilization Through Pharmacist Intervention in a Community Hospital Setting |
Clinical Pharmacist Deaconess Hospital Oklahoma City, Oklahoma |
|
|
2005-2006 |
Debbie Poland |
Perioperative Beta-blocker Use in Patients Undergoing Non-cardiac Vascular Surgery |
Clinical Pharmacy Specialist Norman Regional Health System Norman, Oklahoma |
BCPS |
|
2004-2005 |
Patrick Culley |
Withdrew from program |
||
|
2004-2005 |
Katie Boudreaux (Vandiver) |
An Approach to Glycemic Control in a Community Hospital Intensive Care Unit |
Director of Pharmacy Services Kindred Hospital Oklahoma City, Oklahoma |
|
|
2003-2004 |
Andrea Chbeir (Phillips) |
Evaluation of Fluid Resuscitation in Patients with Sepsis Improving Care of Heart Failure Patients using Quality Performance Indicators |
Director of Clinical Services Affinity Patient Coordination, LLC. Springfield, Illinois PGY2 Residency – Cardiology 2004-2005 University of Oklahoma Oklahoma City, Oklahoma |
BCPS |
|
2003-2004 |
Brian Hughes |
Influencing Meperidine Prescribing Patterns in a Community Hospital Setting |
Pharmacy Supervisor Norman Regional Health System Norman, Oklahoma PGY2 Pediatrics 2004-2005 The Children’s Hospital Denver, Colorado |
BCPS BCIDP |
|
2002-2003 |
Cory Whitley |
PCA Pump Error Reduction: A Proactive Approach Developing Amphotericin B Usage Guidelines in a Community Hospital Setting |
Critical Care Clinical Pharmacist Covenant Health System Lubbock, Texas |
BCCCP |
|
2001-2002 |
Dana Boyers |
Cross-sensitivity of Opioid Analgesics Evaluation of Imipenem Use |
Pharmacist US Oncology Plano, Texas |
BCOP |
|
2001-2002 |
Sheli Kraft |
Cross-sensitivity of Beta-lactam Antibiotics Evaluation of Weight-based Heparin Protocol Use |
Director of Oncology Pharmacy Services Sisters of Mercy Health System St Louis, Missouri PGY2 Hematology/Oncology University of Oklahoma Oklahoma City, Oklahoma |
-----------------------------------------
| 2022-2023 | Resident | Project(s) | Post-Grad Activity | Certification |
|---|---|---|---|---|
| 2022-2023 | Sarah El-Koubysi | Diagnostic Patterns of Cefepime-Related Neurotoxicity in Critically-Ill Patients |
IBD Pharmacist Specialist
SSM Health Oklahoma City, Oklahoma |
|
| 2022-2023 | Trevor Sanders | Clinical Outcomes Associated with Beta-Lactam Antibiotic Treatment in Critically Ill Patients with Augmented Renal Clearance |
Clinical Pharmacy Specialist
Norman Regional Health System Norman, Oklahoma |
|
| 2022-2023 | Carley Welch | Minimizing Altered Mental Status: An In-Depth Analysis of Diphenhydramine Dosing in Elderly Patients |
Staff Pharmacist
Ascension St. John Medical Center Tulsa, Oklahoma |
|
| 2021-2022 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2021-2022 | Miranda Brewer | Optimizing Treatment of Beta-Blocker and Calcium Channel Blocker Overdose in the Emergency Department: A Case Series and Review of the Literature |
ICU Clinical
Pharmacist
PGY-2 Critical Care 2022-2023
|
|
| 2021-2022 | Leith Prise | The Effects of Liposomal Bupivacaine on Patient Length of Stay and Opioid Use Status Post Colorectal Surgery |
Comprehensive Medication Management Pharmacy Specialist
INTEGRIS Health Oklahoma City, Oklahoma |
BCPS |
| 2021-2022 | Brock Snelson | Revenue Analysis Comparing Reimbursement Rates of Cetuximab and Panitumumab in Patients with EGFR-Positive Metastatic Colorectal Cancer for a Hospital-Based Outpatient Infusion Center |
Clinical Pharmacist
Baylor Scott & White Temple, Texas |
BCPS |
| 2020-2021 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2020-2021 | Michaela Metts | Detailing the Gaps: An In-depth Analysis of Adverse Drug Reaction Surveillance and Reporting in a Community Hospital |
Pharmacy Consultant
Oklahoma State Department of Health Oklahoma City, Oklahoma Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma |
MBA, BCPS, AAHIVP |
| 2020-2021 | Cong Vu | Impact of a Pharmacist-Driven Penicillin Skin Testing Protocol in a Community Hospital |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2020-2021 | Charles Whitman | Comparing the Safety and Efficacy of AUC-Based vs. Traditional, Trough Monitoring of Vancomycin in Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia |
Clinical Pharmacy Practitioner, Infectious Diseases
Central Arkansas Veterans Healthcare System Little Rock, Arkansas PGY-2 Infectious Diseases 2021-2022 U.S. Department of Veterans Affairs Oklahoma City, Oklahoma Clinical Pharmacist Specialist Norman Regional Health System, Norman, Oklahoma |
|
| 2019-2020 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2019-2020 | Jerricah Franz | Pharmacist-driven, fixed-dose, four-factor prothrombin complex concentrate (4F-PCC) protocol for major bleeds |
Clinical Pharmacist
North Central Baptist Hospital San Antonio, Texas |
|
| 2019-2020 | Julia Kaminski | Impact of A Pharmacist Driven Opioid Stewardship Program in An Inpatient Setting |
Prescription Drug Monitoring Program Coordinator Clinical Pharmacy Specialist
Coatesville VA Medical Center Coatesville, Pennsylvania |
|
| 2019-2020 | Emily Deremiah | Impact of a Procalcitonin-Guided Algorithm on Antibiotic Duration in Patients Admitted for Sepsis and Community-Acquired Pneumonia |
Critical Care Pharmacist
University Health System, San Antonio, Texas PGY-2 Critical Care 2020-2021 University Health System, San Antonio, Texas |
BCCCP |
| 2018-2019 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2018-2019 | Danielle Norris (Trierweiller) | Impact of a Pharmacist-driven, AUC-based Therapeutic Drug Monitoring Approach on Outcomes in Patients at High Risk for Vancomycin – related Nephrotoxicity |
Clinical Coordinator
SSM Health Oklahoma City, Oklahoma |
BCPS |
| 2018-2019 | K. Alex Ehrhart | Pharmacy Impact on Narcotic Overrides in a Community Hospital Emergency Department |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2018-2019 | Kathleen Sullivan | Pharmacist Role in Optimization of Programmed Death Ligand (PD-L1) Product Selection Based on Reimbursement Data |
Hematology/Oncology Safety Evaluator at the FDA
Silver Spring, Maryland PGY 2 Oncology 2019-2020 NorthShore University Health System Chicago, Evanston, Illinois |
BCPS |
| 2017-2018 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2017-2018 | Jaclyn Coffey | Impact of Skin Testing for Penicillin Allergy in Self-Reported Penicillin Allergic Patients on the Use of Fluoroquinolones, Carbapenems, Aztreonam and Vancomycin in a Community Hospital |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2017-2018 | Mona Kamali | Impact of a Pharmacist-Driven Probiotic Protocol on the Incidence of Antibiotic- and Clostridium difficile-Associated Diarrhea in Hospitalized Patients Receiving Antibiotic Therapy |
Clinical Pharmacist
Texas Health, Denton, Texas |
|
| 2017-2018 | Michael Wisner, Jr. | Evaluating the impact of pharmacy driven interventions on patients with hyperglycemia who have been identified by use of a clinical surveillance software system |
Informatics Pharmacist
Johns Hopkins Health System, Baltimore, Maryland PGY-2 Informatics 2018-2019 Vanderbilt University, Nashville, Tennessee |
|
| 2016-2017 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2016-2017 | Victoria Felder | The Standardization of Admission and Specialty Order Sets to Minimize Duplicate Medication Orders |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2016-2017 | Robert Holliday | Evaluation of the Conversion from Medication Charge on Dispending to Charge on Administration in a Community Hospital |
Clinical Pharmacy Specialist
Saint John Health System, Tulsa, Oklahoma |
BCPS |
| 2016-2017 | Lauren May | Evaluation of Urinary Tract Infection (UTI) Management in a Community Hospital with Subsequent Pathway Development and Implementation |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2015-2016 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2015-2016 | Chris Brown | Shifting from Premixed Nicardipine Injection to Nicardipine Prepared by the Pharmacy: Is It Worth It? |
Clinical Pharmacy Specialist and Residency Program Director
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2015-2016 | Jacqueline Medina | Development and Implementation of a Heparin-Induced-Thrombocytopenia Protocol and Implications on Patient Management and Cost |
Staff Pharmacist
The Hospitals of Providence, El Paso, Texas |
BCPS, BCPPS |
| 2015-2016 | Whitney Rohlman | Evaluation of Pyxis Overrides and Development of Policies to Promote Improvement |
Director of Pharmacy (2017 – present)
Pratt Regional Medical Center, Pratt, Kansas |
BCPS |
| 2014-2015 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2014-2015 | Elizabeth Rathgeber | Appropriateness of Iohexol and Iodixanol Use for Prevention of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization |
Clinical Pharmacist
The Children’s Hospital at OU Medical Center, Oklahoma City, Oklahoma |
|
| 2014-2015 | Samantha Sepulveda | Development and Implementation of a Protocol for Reversing the Effects of Anticoagulants for Use in a Community Hospital |
Pharmacist
Oklahoma Heart Hospital South, Oklahoma City, OK |
|
| 2014-2015 | Lysse Vadder | Analysis and Reduction of Adverse Drug Events Associated with Opioid Use in the Community Hospital Setting |
Clinical Pharmacist
Integris Bass Baptist Health Center, Enid, Oklahoma |
BCPS, SIDP |
| 2013-2014 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2013-2014 | Justin Booth | Impact of Nutrition Support Team Implementation on Parenteral Nutrition Practices in a Community Hospital |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2013-2014 | Kimberly Whitley (Curley) | Development and Implementation of a Standardized Risk Stratification Protocol for Safe Handling of Hazardous Drugs According to NIOSH |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2013-2014 | Minh Truong | War on Pharmaceutical Waste |
Institutional Pharmacist
Mayo Clinic, Jacksonville, Florida |
|
| 2012-2013 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2012-2013 | Shamama Burney | Appropriateness of Acid Suppression Therapy in a Community Hospital |
PACT Clinical Pharmacy Specialist
Phoenix Veterans Health Care System – Northeast Clinic. Scottsdale, Arzona |
|
| 2012-2013 | Sarah Payne | Evaluation and Implementation of a Multi-dose Medication Dispensing at Discharge Policy and Procedure |
Chief Operating Officer
Health Candi, Inc. PGY2 Residency – Ambulatory Care 2013-2014 University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma |
|
| 2012-2013 | Tiffany Sanders (White) | Conversion from Activated Partial Thromboplastin Time (aPTT) to Antifactor Xa Levels for Monitoring of Unfractionated Heparin (UFH) Infusions |
PRN Pharmacist
St. Anthony Hospital Shawnee, Oklahoma |
BCPS |
| 2011-2012 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2011-2012 | Austin Bertram | Development and Evaluation of a Program to Document Pharmacist Order Processing Interventions |
Pharmacy Infusion Manager
Coram CVS/Specialty Infusion, Oklahoma City, Oklahoma |
|
| 2011-2012 | Jenny Stemm | Conversion to Medication Charge upon Administration in a Community Hospital |
Manager, Pharmacy Services
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2011-2012 | Karen Thompson | Implementation of Risk Evaluation and Mitigation Strategy (REMS) Requirements and Compliance in the Hospital Setting |
Manager of Pharmacy Services and Medication Safety
Mercy Health System, Oklahoma City, Oklahoma |
BCPS |
| 2010-2011 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2010-2011 | Trevor Knol | Evaluation of Inappropriate Medication Use in Hospitalized Patients Based on the Beers Criteria |
Clinical/Staff Pharmacist
Oklahoma Heart Hospital, Oklahoma City, Oklahoma |
|
| 2010-2011 | Stefanie Stogsdill | Implementation of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency |
Clinical Coordinator of Pharmacy Services
Northeastern Health System, Tahlequah, Oklahoma |
BCPS |
| 2008-2009 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2008-2009 | Jerri Cody | Increasing Pharmacist Review of Medications Prior to Retrieval from Automated Dispensing Cabinets |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
|
| 2008-2009 | Lisa Mayer | Development of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency |
Clinical Pharmacist
Oklahoma Heart Hospital South, Oklahoma City, Oklahoma |
BCPS |
| 2006-2007 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2006-2007 | Lyndsay Sheperd | Trends in Treatment of Clostridium difficile associated Disease in a Community Hospital Setting |
Critical Care Pharmacy Specialist
PGY2 Residency - Critical Care 2007-2008
|
BCPS, BCCCP |
| 2005-2006 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2005-2006 | Emily Lam (Babcock) | Improved Carbapenem Utilization Through Pharmacist Intervention in a Community Hospital Setting |
Clinical Pharmacist
Deaconess Hospital, Oklahoma City, Oklahoma |
|
| 2005-2006 | Debbie Poland | Perioperative Beta-blocker Use in Patients Undergoing Noncardiac Vascular Surgery |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2004-2005 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2004-2005 | Katie Boudreaux (Vandiver) | An Approach to Glycemic Control in a Community Hospital Intensive Care Unit |
Director of Pharmacy Services
Kindred Hospital, Oklahoma City, Oklahoma |
|
| 2022-2023 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2022-2023 | Sarah El-Koubysi | Diagnostic Patterns of Cefepime-Related Neurotoxicity in Critically-Ill Patients |
IBD Pharmacist Specialist
SSM Health Oklahoma City, Oklahoma |
|
| 2022-2023 | Trevor Sanders | Clinical Outcomes Associated with Beta-Lactam Antibiotic Treatment in Critically Ill Patients with Augmented Renal Clearance |
Clinical Pharmacy Specialist
Norman Regional Health System Norman, Oklahoma |
|
| 2022-2023 | Carley Welch | Minimizing Altered Mental Status: An In-Depth Analysis of Diphenhydramine Dosing in Elderly Patients |
Staff Pharmacist
Ascension St. John Medical Center Tulsa, Oklahoma |
|
| 2021-2022 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2021-2022 | Miranda Brewer | Optimizing Treatment of Beta-Blocker and Calcium Channel Blocker Overdose in the Emergency Department: A Case Series and Review of the Literature |
ICU Clinical Pharmacist
PGY-2 Critical Care 2022-2023
|
|
| 2021-2022 | Leith Prise | The Effects of Liposomal Bupivacaine on Patient Length of Stay and Opioid Use Status Post Colorectal Surgery |
Comprehensive Medication Management Pharmacy Specialist
INTEGRIS Health Oklahoma City, Oklahoma |
BCPS |
| 2021-2022 | Brock Snelson | Revenue Analysis Comparing Reimbursement Rates of Cetuximab and Panitumumab in Patients with EGFR-Positive Metastatic Colorectal Cancer for a Hospital-Based Outpatient Infusion Center |
Clinical Pharmacist
Baylor Scott & White Temple, Texas |
BCPS |
| 2020-2021 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2020-2021 | Michaela Metts | Detailing the Gaps: An In-depth Analysis of Adverse Drug Reaction Surveillance and Reporting in a Community Hospital |
Pharmacy Consultant
Clinical Pharmacist Specialist
|
MBA, BCPS, AAHIVP |
| 2020-2021 | Cong Vu | Impact of a Pharmacist-Driven Penicillin Skin Testing Protocol in a Community Hospital |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2020-2021 | Charles Whitman | Comparing the Safety and Efficacy of AUC-Based vs. Traditional, Trough Monitoring of Vancomycin in Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia |
Clinical Pharmacy Practitioner, Infectious Diseases
PGY-2 Infectious Diseases 2021-2022
Clinical Pharmacist Specialist
|
|
| 2019-2020 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2019-2020 | Jerricah Franz | Pharmacist-driven, fixed-dose, four-factor prothrombin complex concentrate (4F-PCC) protocol for major bleeds |
Clinical Pharmacist
North Central Baptist Hospital San Antonio, Texas |
|
| 2019-2020 | Julia Kaminski | Impact of A Pharmacist Driven Opioid Stewardship Program in An Inpatient Setting |
Prescription Drug Monitoring Program Coordinator Clinical Pharmacy Specialist
Coatesville VA Medical Center Coatesville, Pennsylvania |
|
| 2019-2020 | Emily Deremiah | Impact of a Procalcitonin-Guided Algorithm on Antibiotic Duration in Patients Admitted for Sepsis and Community-Acquired Pneumonia |
Critical Care Pharmacist
PGY-2 Critical Care 2020-2021
|
BCCCP |
| 2018-2019 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2018-2019 | Danielle Norris (Trierweiller) | Impact of a Pharmacist-driven, AUC-based Therapeutic Drug Monitoring Approach on Outcomes in Patients at High Risk for Vancomycin – related Nephrotoxicity |
Clinical Coordinator
SSM Health Oklahoma City, Oklahoma |
BCPS |
| 2018-2019 | K. Alex Ehrhart | Pharmacy Impact on Narcotic Overrides in a Community Hospital Emergency Department |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2018-2019 | Kathleen Sullivan | Pharmacist Role in Optimization of Programmed Death Ligand (PD-L1) Product Selection Based on Reimbursement Data |
Hematology/Oncology Safety Evaluator at the FDA
PGY 2 Oncology 2019-2020
|
BCOP |
| 2017-2018 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2017-2018 | Jaclyn Coffey | Impact of Skin Testing for Penicillin Allergy in Self-Reported Penicillin Allergic Patients on the Use of Fluoroquinolones, Carbapenems, Aztreonam and Vancomycin in a Community Hospital |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2017-2018 | Mona Kamali | Impact of a Pharmacist-Driven Probiotic Protocol on the Incidence of Antibiotic- and Clostridium difficile-Associated Diarrhea in Hospitalized Patients Receiving Antibiotic Therapy |
Clinical Pharmacist
Texas Health, Denton, Texas |
|
| 2017-2018 | Michael Wisner, Jr. | Evaluating the impact of pharmacy driven interventions on patients with hyperglycemia who have been identified by use of a clinical surveillance software system |
Informatics Pharmacist
PGY-2 Informatics 2018-2019
|
|
| 2016-2017 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2016-2017 | Victoria Felder | The Standardization of Admission and Specialty Order Sets to Minimize Duplicate Medication Orders |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2016-2017 | Robert Holliday | Evaluation of the Conversion from Medication Charge on Dispending to Charge on Administration in a Community Hospital |
Clinical Pharmacy Specialist
Saint John Health System, Tulsa, Oklahoma |
BCPS |
| 2016-2017 | Lauren May | Evaluation of Urinary Tract Infection (UTI) Management in a Community Hospital with Subsequent Pathway Development and Implementation |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2015-2016 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2015-2016 | Chris Brown | Shifting from Premixed Nicardipine Injection to Nicardipine Prepared by the Pharmacy: Is It Worth It? |
Clinical Pharmacy Specialist and Residency Program Director
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2015-2016 | Jacqueline Medina | Development and Implementation of a Heparin-Induced-Thrombocytopenia Protocol and Implications on Patient Management and Cost |
Staff Pharmacist
The Hospitals of Providence, El Paso, Texas |
BCPS, BCPPS |
| 2015-2016 | Whitney Rohlman | Evaluation of Pyxis Overrides and Development of Policies to Promote Improvement |
Director of Pharmacy (2017 – present)
Pratt Regional Medical Center, Pratt, Kansas |
BCPS |
| 2014-2015 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2014-2015 | Elizabeth Rathgeber | Appropriateness of Iohexol and Iodixanol Use for Prevention of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization |
Clinical Pharmacist
The Children’s Hospital at OU Medical Center, Oklahoma City, Oklahoma |
|
| 2014-2015 | Samantha Sepulveda | Development and Implementation of a Protocol for Reversing the Effects of Anticoagulants for Use in a Community Hospital |
Pharmacist
Oklahoma Heart Hospital South, Oklahoma City, OK |
|
| 2014-2015 | Lysse Vadder | Analysis and Reduction of Adverse Drug Events Associated with Opioid Use in the Community Hospital Setting |
Clinical Pharmacist
Integris Bass Baptist Health Center, Enid, Oklahoma |
BCPS, SIDP |
| 2013-2014 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2013-2014 | Justin Booth | Impact of Nutrition Support Team Implementation on Parenteral Nutrition Practices in a Community Hospital |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2013-2014 | Kimberly Whitley (Curley) | Development and Implementation of a Standardized Risk Stratification Protocol for Safe Handling of Hazardous Drugs According to NIOSH |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2013-2014 | Minh Truong | War on Pharmaceutical Waste |
Institutional Pharmacist
Mayo Clinic, Jacksonville, Florida |
|
| 2012-2013 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2012-2013 | Shamama Burney | Appropriateness of Acid Suppression Therapy in a Community Hospital |
PACT Clinical Pharmacy Specialist
Phoenix Veterans Health Care System – Northeast Clinic. Scottsdale, Arzona |
|
| 2012-2013 | Sarah Payne | Evaluation and Implementation of a Multi-dose Medication Dispensing at Discharge Policy and Procedure |
Chief Operating Officer
PGY2 Residency – Ambulatory Care 2013-2014
|
|
| 2012-2013 | Tiffany Sanders (White) | Conversion from Activated Partial Thromboplastin Time (aPTT) to Antifactor Xa Levels for Monitoring of Unfractionated Heparin (UFH) Infusions |
PRN Pharmacist
St. Anthony Hospital Shawnee, Oklahoma |
BCPS |
| 2011-2012 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2011-2012 | Austin Bertram | Development and Evaluation of a Program to Document Pharmacist Order Processing Interventions |
Pharmacy Infusion Manager
Coram CVS/Specialty Infusion, Oklahoma City, Oklahoma |
|
| 2011-2012 | Jenny Stemm | Conversion to Medication Charge upon Administration in a Community Hospital |
Manager, Pharmacy Services
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2011-2012 | Karen Thompson | Implementation of Risk Evaluation and Mitigation Strategy (REMS) Requirements and Compliance in the Hospital Setting |
Manager of Pharmacy Services and Medication Safety
Mercy Health System, Oklahoma City, Oklahoma |
BCPS |
| 2010-2011 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2010-2011 | Trevor Knol | Evaluation of Inappropriate Medication Use in Hospitalized Patients Based on the Beers Criteria |
Clinical/Staff Pharmacist
Oklahoma Heart Hospital, Oklahoma City, Oklahoma |
|
| 2010-2011 | Stefanie Stogsdill | Implementation of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency |
Clinical Coordinator of Pharmacy Services
Northeastern Health System, Tahlequah, Oklahoma |
BCPS |
| 2001-2002 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2008-2009 | Jerri Cody | Increasing Pharmacist Review of Medications Prior to Retrieval from Automated Dispensing Cabinets |
Clinical Pharmacist Specialist
Norman Regional Health System, Norman, Oklahoma |
|
| 2008-2009 | Lisa Mayer | Development of a Standard Protocol for Medication Dose Adjustments in Patients with Renal Insufficiency |
Clinical Pharmacist
Oklahoma Heart Hospital South, Oklahoma City, Oklahoma |
BCPS |
| 2006-2007 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2006-2007 | Lyndsay Sheperd | Trends in Treatment of Clostridium difficile associated Disease in a Community Hospital Setting |
Critical Care Pharmacy Specialist
PGY2 Residency - Critical Care 2007-2008
|
BCPS, BCCCP |
| 2005-2006 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2005-2006 | Emily Lam (Babcock) | Improved Carbapenem Utilization Through Pharmacist Intervention in a Community Hospital Setting |
Clinical Pharmacist
Deaconess Hospital, Oklahoma City, Oklahoma |
|
| 2005-2006 | Debbie Poland | Perioperative Beta-blocker Use in Patients Undergoing Noncardiac Vascular Surgery |
Clinical Pharmacy Specialist
Norman Regional Health System, Norman, Oklahoma |
BCPS |
| 2004-2005 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2004-2005 | Katie Boudreaux (Vandiver) | An Approach to Glycemic Control in a Community Hospital Intensive Care Unit |
Director of Pharmacy Services
Kindred Hospital, Oklahoma City, Oklahoma |
|
| 2003-2004 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2003-2004 | Andrea Chbeir (Phillips) |
Evaluation of Fluid Resuscitation in Patients with Sepsis Improving Care of Heart Failure Patients using Quality Performance Indicators |
Director of Clinical Services
PGY2 Residency - Cardiology 2004-2005
|
BCPS |
| 2003-2004 | Brian Hughes | Influencing Meperidine Prescribing Patterns in a Community Hospital Setting |
Pharmacy Supervisor
PGY2 Pediatrics 2004-2005
|
BCPS, BCIDP |
| 2002-2003 | Resident | Project(s) | Post-Grad Activity | Certification |
| 2002-2003 | Cory Whitley |
PCA Pump Error Reduction: A Proactive Approach Developing Amphotericin B Usage Guidelines in a Community Hospital Setting |
Critical Care Clinical Pharmacist
Covenant Health System, Lubbock, TX |
BCCCP |
| 2001-2002 | Dana Boyers | Cross-sensitivity of Opioid Analgesics Evaluation of Imipenem Use |
Pharmacist
US Oncology, Plano, TX |
BCOP |
| 2001-2002 | Sheli Kraft |
Cross-sensitivity of Beta-lactam Antibiotics Evaluation of Weight-based Heparin Protocol Use |
Director of Oncology Pharmacy Services Sisters of Mercy Health System St Louis, Missouri
PGY2 Hematology/Oncology
|
